Answers are grounded in this paper and cite their sources.
Disulfidptosis is a regulated cell-death phenotype in which high SLC7A11-dependent cystine uptake becomes hazardous when reducing capacity falls. In glucose-limited experimental systems, depletion of NADPH permits intracellular disulfide accumulation, aberrant disulfide bonding of actin-associated proteins, cytoskeletal collapse, and cell death. Exercise changes whole-body substrate use, blood flow, redox signaling, endocrine output, and immune traffic; these observations motivate a possible intersection with tumor disulfide stress. Yet exercise has not been shown to induce bona fide disulfidptosis in tumors, and physiological exercise does not reproduce the near-complete glucose withdrawal used in many cell-culture experiments. In this Perspective, we distinguish established molecular evidence from indirect exercise-oncology observations and propose a falsifiable framework centered on cystine flux, intracellular NADPH, glucose delivery, and actin disulfide chemistry. It examines opposing exercise effects, tumor heterogeneity, measurement and rescue criteria, and patient-level safety. The proposed link should be tested through paired tumor and host sampling, stable-isotope tracing, genetic perturbation of SLC7A11 and WAVE-regulatory complex components, and orthogonal disulfide assays. Until those experiments are performed, exercise is best understood as an established supportive intervention with multiple effects on cancer biology, while disulfidptosis remains an unproven explanation for any particular exercise-related antitumor outcome.
No takes yet. Share an insight, caveat, or question.
康 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: